BIO Bio-Rad Laboratories Earnings and EPS analysis

EPS in 2026 (TTM): $5.83

Last Report Period Date: Mar 31, 2026

As of June this year, based on Bio-Rad Laboratories's most recent financial report, the company's trailing twelve months EPS is $5.83. During 2025, BIO reported a per-share earnings of $27.87, which shows a rise compared to the EPS of -$65.36 recorded in 2024. Bio-Rad Laboratories's EPS for the quarterly period ending on Mar 31, 2026 came in at -$19.55.

The yearly earnings per share during 2025 was $27.87, a rise of 142.6% compared to -$65.36 recorded in 2024. Over the quarter ending Mar 31, 2026, the earnings per share came in at -$19.55, reflecting a 953.7% decline compared to the same quarter a year earlier. As of March 2026, the TTM EPS is $5.83. During 2024, the annual earnings per share was -$65.36, representing a decrease of 199.5% compared to 2023.

Bio-Rad Laboratories has recorded a decline in earnings per share of 953.7% over the past 12 months (YoY, quarterly). Bio-Rad Laboratories had an average annual EPS growth of -26.3% in the last five years. When assessed over a ten-year period, BIO's average EPS annual growth was 22.2%.